From Lab to patient - CREATIC LabtoP Talks
Hospital Exemption and Advanced Therapy Medicinal Products (ATMPs)
| WHEN? | November 22, 2024 at 2:00 - 2:45 p.m. (CET) |
| WHERE? | Online via Zoom |
| WHO? | Inge Marie Svane, Herlev Hospital & Jakob Wested, CeBIL University of Copenhagen |
| WHY? | ATMP’s, Hospital Exemption, Access to medicine |
| HOW? | Sign up here |
The CREATIC team are happy to invite you to the first CREATIC LabtoP talk, talks about bringing ATMP’s from lab to patients. This time considering experiences and perspectives on the Hospital Exemption as a pathway from lab to patient.
The conversation will take place between Jakob Wested, associate professor, in Center for Advanced Studies in Bioscience Innovation Law (CeBIL) and PI in the CREATIC project, and Dr. Inge Marie Svane, Professor in Clinical cancer immune therapy and director of the translational research centre, Center for Cancer Immune Therapy (CCIT) at Herlev Hospital in Denmark.
Whether you're a healthcare professional, researcher, policymaker, or simply interested in cutting-edge medical advancements, this session will provide important perspectives on how hospital exemptions and ATMPs may shape the future of medical innovation and collaboration across sectors.
We encourage you to engage actively by submitting your questions in the chat throughout the session. Please join us for this exciting journey into the future of healthcare!
Sign-up
Please sign up here to get your Zoom-link for participation no later than 22 November 2024, 10:00.
More about CREATIC here and sign up for the CREATIC ATMP Newsletter here. The newsletter is published four times annually, and provides an overview of news and updates on ATMPs at the intersection of regulation, society and patients.